DOSSIER · UPDATED 18 JUN 2026

Aprea Therapeutics

Aprea focuses on the discovery and development of novel anticancer compounds reactivating the tumor suppressor protein p53.

aprea.com ↗Claim this profile

Founded: 2003
Headcount: 35
Open roles: 0
Last raised: Post Ipo Equity · $30M

SECTION I · THE BRIEF

Inside Aprea Therapeutics

Brief #89661Updated 18 JUN 2026DOYLESTOWNMEDICAL ORGANIZATIONSPOST IPO EQUITY

Employbl Dossier

Aprea Therapeutics

Aprea focuses on the discovery and development of novel anticancer compounds reactivating the tumor suppressor protein p53.

Founded: 2003
Headcount: 35
Open roles: 0
Last raised: Post Ipo Equity · $30M

Section II · Premium ProfileMembers only

01Engineering interview process at Aprea TherapeuticsLocked
02Tech stack & infrastructure choicesLocked
03Culture & day-to-day work styleLocked
04Why join now vs. 6 months from nowLocked
05Hiring focus & open headcount by teamLocked
06Comp philosophy and band contextLocked

Open Aprea Therapeutics brief Sign in

7-day free trial · $25/mo · cancel anytime

LEADERSHIP

Founders & key people

Oren Gilad

Klas G. Wiman

Galina Selivanova

OPEN ROLES

Hiring at Aprea Therapeutics

No open roles listed right now. Check back soon or search all jobs →

FUNDING

Capital raised

Total Amount Raised: